FDA Brief

Warning letters Drugs

FDA warning letter to

TKTX Store

High riskIssued Feb 25, 2025Posted Mar 4, 2025Center for Drug Evaluation and Research (CDER)

FDA warns TKTX Store it sells unapproved lidocaine and prilocaine numbing creams online for tattooing and cosmetic procedures.

What happened

FDA reviewed TKTX Store's website, tktxstore.com, and its Instagram page, where the numbing creams are offered for sale in the United States without a prescription. The labeling promotes the products for pain relief during tattooing, microblading, laser hair removal and other cosmetic procedures. FDA said the products are unapproved new drugs and misbranded because they do not meet the conditions for legal over-the-counter marketing.

What FDA found

  1. The numbing creams are new drugs sold without an FDA-approved application.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  2. The products are labeled for tattooing, piercing and laser procedures, uses that are not allowed under the over-the-counter external analgesic monograph.

    FD&C Act section 505G, 21 U.S.C. 355h; OTC Monograph M017
  3. Mithra+ and J-PRO contain lidocaine at strengths above the permitted level, and J-PRO combines lidocaine with prilocaine, which the monograph does not allow.

    OTC Monograph M017; FD&C Act section 505G
  4. The TKTX creams are labeled with prilocaine, which no OTC monograph allows, and with epinephrine outside the permitted range.

    OTC Monographs M017 and M015; FD&C Act section 505G
  5. The products are misbranded because they are nonprescription drugs that do not meet the requirements for marketing under section 505G.

    FD&C Act section 502(ee), 21 U.S.C. 352(ee)
  6. Shipping these unapproved and misbranded drugs across state lines is prohibited.

    FD&C Act sections 301(a) and 301(d), 21 U.S.C. 331(a) and 331(d)

What FDA wants

FDA asks the firm to write within 15 working days describing the specific steps taken to fix the violations and prevent them from happening again, with supporting documentation, sent to CDER's Office of Unapproved Drugs and Labeling Compliance. If corrective action cannot be finished in that time, the firm must explain why and give a completion date.

Who should pay attention

  • tattoo and permanent-makeup studios and their clients
  • online sellers and distributors of topical numbing creams
  • marketplaces and importers that list or bring in numbing creams

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk